Add-on treatment with mirabegron may improve quality of life in patients with benign prostatic hyperplasia complaining of persistent storage symptoms after tamsulosin monotherapy

BACKGROUND: The aim of this study was to evaluate the change in lower urinary tract symptoms and quality of life (QoL) after combination therapy of solifenacin and mirabegron in patients with benign prostatic hyperplasia presenting with persistent storage symptoms after treatment with tamsulosin. MA...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Tae Wook, Chung, Hyun Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750565/
https://www.ncbi.nlm.nih.gov/pubmed/33414845
http://dx.doi.org/10.1177/1756287220974130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750565/
https://www.ncbi.nlm.nih.gov/pubmed/33414845
http://dx.doi.org/10.1177/1756287220974130

Ejemplares similares